Steatotic Liver Disease Nomenclature Implementation Symposium
90 minute: Talks + Panel Discussion
90 minute: Talks + Panel Discussion
This session delves into the progress in diagnosing At-Risk-MASH, with discussions on the viability of achieving MASH resolution through drug development and the potential of non-invasive tests (NITs) for outcome prediction. The session also explores a Ph
University of California, San Francisco
University of Southern California
Duke University
Indiana University School of Medicine
The Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine
Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland
Tampa General Hospital
Stanford University School of Medicine